Ocuphire Pharma, Inc. OCUP

Full chart Compare
Set alert

Price alert · OCUP

All alert types
1.17 0.00 (+0.00%)

At closeOct 23, 2024, 4:00 PM EDT

1.07 Day range 1.36

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $589.00KExpenses → Selling, General & Admin: $11.95MExpenses → Research & Development: $17.65MExpenses → Income Tax: $12.00KGross Profit → Expenses: $19.04MRevenue → Gross Profit: $19.04MRevenue → Cost of Revenue: $6.00KNet Loss → Expenses: $9.99MOther Income$589.00KGross Profit$19.04MNet Loss$9.99MCost of Revenue$6.00KExpenses$29.62MSelling, General & Admin$11.95MResearch & Development$17.65MIncome Tax$12.00KRevenue$19.05M

Latest period ending Dec 31, 2023 · select a line to chart its full history

OCUP annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
19.05M39.85M589.00K00
19.05M39.85M589.00K00
-10.56M18.23M-22.70M-19.97M-4.19M
-9.99M17.89M-56.69M-24.62M-6.17M
-0.460.87-3.82-5.28-2.17
OCUP annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
50.50M42.63M24.53M16.40M1.54M
53.95M48.99M26.08M17.68M1.78M
4.04M2.75M3.85M31.15M9.34M
49.91M46.24M22.22M-13.47M-7.56M
OCUP annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-1.11M14.31M-19.37M-6.80M-3.59M
8.98M3.79M27.61M21.12M4.70M
7.87M18.10M8.13M14.86M1.09M